SRPT sarepta.com: Nilai bisnis marang pendapatan

Logo perusahaan publik Sarepta Therapeutics (SRPT)

The integration of AI into DNA modeling is accelerating drug development, as evidenced by the shift in EV/Sales for Sarepta Therapeutics, Inc. (SRPT). The value of 865.80 reflects the current magnitude of this trend. A monopoly in Duchenne therapy via Elevidys guarantees leadership. High product pricing creates operational leverage, enabling the company to rapidly scale profits and recoup previous R&D expenditures.

SRPT Rasio nilai perusahaan marang pendapatan Sarepta Therapeutics (23.11.2025 - 20.11.2026)

Rincian metrik keuangan lan pasar Sarepta Therapeutics (SRPT)

- rega lan prakiraan konsensus rega:
- informasi babagan dhuwit lan arus kas:
Barang utama Sarepta

Sarepta Therapeutics, Inc. (SRPT) maintains dominance in the gene therapy segment, enabling the company to command premium pricing for its unique drugs. The EV/Sales metric combines market capitalization and net debt, comparing the total enterprise value to the volume of generated revenue. This indicator determines the price of every dollar of revenue, eliminating the impact of debt load on the valuation. An increase in this ratio reflects market optimism regarding future sales. Analyzing the EV/Sales chart helps identify asset overvaluation or undervaluation in a timely manner.

Analisis pesaing Sarepta Therapeutics, Inc.

TEM (tempus.com) - Rasio nilai perusahaan marang pendapatan|qiagen.com (QGEN) - Rasio nilai perusahaan marang pendapatan|Ionis (IONS) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Repligen|Avidity (RNA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales CRSP|Rasio total nilai perusahaan marang pendapatan GeneDx|Rasio nilai perusahaan marang pendapatan Ultragenyx RARE|Rasio total nilai perusahaan marang pendapatan Beam Therapeutics (BEAM)|twistbioscience.com - Multiplikator EV/Sales|10x Genomics, Inc. - Koefisien nilai perusahaan marang pendapatan|NTLA (Intellia Corp) - Nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan stoketherapeutics.com|Nilai perusahaan marang pendapatan BLFS|Nilai perusahaan marang pendapatan Wave Life Sciences Corp (WVE)|Multiplikator EV/Sales MAZE|Rasio total nilai perusahaan marang pendapatan Sionna Therapeutics Inc|Rasio nilai perusahaan marang pendapatan Prime Medicine Corp PRME|tayshagtx.com (TSHA) - Multiplikator nilai perusahaan marang pendapatan|QURE - Rasio nilai perusahaan marang pendapatan|MeiraGTx Holdings (MGTX) - Nilai perusahaan marang pendapatan|Regenxbio (RGNX) - Rasio nilai perusahaan marang pendapatan|SLDB - Rasio total nilai perusahaan marang pendapatan|OCGN (Ocugen Inc) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PACB|Rasio nilai perusahaan marang pendapatan Benitec (BNTC)|Design Therapeutics Inc - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rocket Pharma RCKT|Multiplikator EV/Sales 4DMT FDMT|LXEO - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Korro Bio Inc.|EDIT: Multiplikator EV/Sales|SLN - Rasio total nilai perusahaan marang pendapatan|PRQR (ProQR Therapeutics) - Multiplikator EV/Sales|codexis.com (CDXS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales SGMO|Multiplikator EV/Sales Nautilus Biotechnology, Inc. (NAUT)|Multiplikator EV/Sales MGX (Metagenomi Inc.)|Nilai bisnis marang pendapatan DTIL|Generation Bio Co. - Multiplikator EV/Sales|BOLD: Rasio nilai perusahaan marang pendapatan|XCUR (Exicure, Inc.) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan IMNN|Rasio nilai perusahaan marang pendapatan RXi Pharmaceuticals|mustangbio.com (MBIO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan TransCode (RNAZ)|Bionano Genomics Inc. - Rasio nilai perusahaan marang pendapatan|Applied DNA Sciences - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan bluebirdbio.com (BLUE)|IPA - Rasio nilai perusahaan marang pendapatan|OMGA - Multiplikator EV/Sales|OMIC (Singular Genomics Systems, Inc.) - Nilai perusahaan marang pendapatan|Regulus Therapeutics Inc - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Syros Pharmaceuticals|Nilai perusahaan marang pendapatan Telesis Bio (TBIO)|Multiplikator EV/Sales TCON|UBX - Multiplikator nilai perusahaan marang pendapatan